Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Susheel Durani is active.

Publication


Featured researches published by Susheel Durani.


Biochemical and Biophysical Research Communications | 1984

Cis isomer of centchroman — A selective ligand for the microsomal antiestrogen binding site

Ashraf Saeed; Neelam Durani; Susheel Durani; Suprabhat Ray; Randhir S. Kapil

Several compounds structurally related to the triarylethylene antiestrogens, but possessing weak estrogen receptor affinities, were assessed for their ability to interact with the microsomal antiestrogen binding site. While all the compounds tested did interact with this site their relative affinities were somewhat lower than that of tamoxifen. One of these, viz., the cis isomer of centchroman, has however emerged as a selective ligand for the antiestrogen binding site since its estrogen receptor affinity is nearly 50,000 times lower on a relative scale.


Journal of The Chemical Society-perkin Transactions 1 | 1983

A novel rearrangement reaction: single-step conversion of 2-(6-carboxy-3-oxoheptyl)-3,4-dihydro-6-methoxynaphthalen-1 (2H)-one into 1-(3-carboxybutyl)-2-(2-carboxyethyl)-3,4-dihydro-6-methoxynaphthalene

Susheel Durani; Randhir S. Kapil

The synthesis of 2-(2-carboxyethyl)-1-(3-carboxypropyl)-3,4-dihydro-6-methoxynaphthalene (28) and the homologous diacid (30) has been achieved in a single step from the 2-(6-carboxy-3-oxoalkyl)-3,4-dihydro-6-methoxynaphthalen-1(2H)-ones (22) and (24), respectively, via a novel acid-catalysed cyclisation–rearrangement reaction. The structure of the diacids (28) and (30) is supported by the high resolution mass spectrometric data of their respective dimethyl esters (29) and (31). The aromatic methoxy-group and the carboxy-function at C-6 in the side chain are critical for the rearrangement, but not for the cyclisation, part of the reaction. Based on this and other observations a mechanism for this novel rearrangement reaction has been proposed.


Journal of Medicinal Chemistry | 1990

Structure-activity relationship of antiestrogens. Effect of the side chain and its position on the activity of 2,3-diaryl-2H-1-benzopyrans

Arun P. Sharma; Ashraf Saeed; Susheel Durani; Randhir S. Kapil


Journal of Medicinal Chemistry | 1990

Structure-activity relationship of antiestrogens. Studies on 2,3-diaryl-1-benzopyrans.

Ashraf Saeed; Arun P. Sharma; Neelam Durani; Raka Jain; Susheel Durani; Randhir S. Kapil


Journal of Medicinal Chemistry | 1990

Structure-activity relationship of antiestrogens. Phenolic analogues of 2,3-diaryl-2H-1-benzopyrans

Arun P. Sharma; Ashraf Saeed; Susheel Durani; Randhir S. Kapil


Journal of Medicinal Chemistry | 1985

Structure-activity relationship of estrogens: receptor affinity and estrogen antagonist activity of certain (E)- and (Z)-1,2,3-triaryl-2-propen-1-ones.

Shubhra Mittal; Susheel Durani; Randhir S. Kapil


Journal of Medicinal Chemistry | 1989

Structure-activity relationship of antiestrogens: a study using triarylbutenone, benzofuran, and triarylfuran analogues as models for triarylethylenes and triarylpropenones

Neelam Durani; Raka Jain; Ashraf Saeed; Dinesh K. Dikshit; Susheel Durani; Randhir S. Kapil


Journal of Mass Spectrometry | 1985

Stereospecific adduct ion formation in the chemical ionization mass spectra of E‐ and Z‐1,2,3‐triaryl‐2‐propen‐1‐ones

K. P. Madhusudanan; Shubhra Mittal; Susheel Durani; Randhir S. Kapil


Journal of Mass Spectrometry | 1985

Fragmentation and rearrangement reactions in certain 1,2,3-triaryl-2-propen-1-ones following electron impact and chemical ionization†

K. P. Madhusudanan; Shubhra Mittal; Susheel Durani; Randhir S. Kapil


ChemInform | 1983

Antifertility agents. 38. Effect of the side chain and its position on the activity of 3,4-diarylchromans

Mohammad Salman; Suprabhat Ray; Anil K. Agarwal; Susheel Durani; B.S. Setty; V. P. Kamboj; N. Anand

Collaboration


Dive into the Susheel Durani's collaboration.

Top Co-Authors

Avatar

Randhir S. Kapil

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Ashraf Saeed

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

K. P. Madhusudanan

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Shubhra Mittal

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Arun P. Sharma

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Neelam Durani

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Raka Jain

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Suprabhat Ray

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

B.S. Setty

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

D. M. Reddy

Central Drug Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge